Today: 21 May 2026
Browse Category

TWSE:2408.TW 20 January 2026 - 8 February 2026

Nanya Technology stock slides into Taiwan’s Lunar New Year shutdown — what investors watch next

Nanya Technology stock slides into Taiwan’s Lunar New Year shutdown — what investors watch next

Nanya Technology shares fell 4% to T$264 on Friday, extending a five-day slide as Taiwan traders cut risk ahead of the Lunar New Year break. The TAIEX closed down 18.35 points at 31,782.92. Nanya’s January sales jumped 27% from December, but memory-chip stocks faced pressure amid global supply concerns and rising costs. Trading pauses after Feb. 11, resuming Feb. 23.
8 February 2026
·
Nanya Technology stock price in focus as 2408 heads into Taiwan open on DRAM squeeze

Nanya Technology stock price in focus as 2408 heads into Taiwan open on DRAM squeeze

Nanya Technology shares closed Friday at T$271.50, up 1.9%, after the company posted Q4 net income of T$11.083 billion and outlined a T$50 billion capital spending plan for 2026. President Lee Pei-ing expects DRAM prices to rise further this quarter amid shortages. Rising memory costs are prompting device makers to hike prices, with analysts forecasting declines in global smartphone and PC sales for 2026.
26 January 2026
··
Nanya Technology stock price: T$2.05 bln equipment buy keeps Taiwan DRAM maker in focus ahead of Monday

Nanya Technology stock price: T$2.05 bln equipment buy keeps Taiwan DRAM maker in focus ahead of Monday

Nanya Technology shares closed up 1.88% at T$271.5 Friday after disclosing a T$2.053 billion facilities-equipment purchase approved by its chairman. Trading was volatile, with shares swinging from T$275.5 to T$256 before rebounding. The company clarified that a rumored T$50 billion 2026 capex plan has not been approved by the board. Taiwan trading resumes Jan. 26.
25 January 2026
··
Nanya Technology stock price hits limit-down in Taipei as traders digest DRAM call

Nanya Technology stock price hits limit-down in Taipei as traders digest DRAM call

Nanya Technology shares fell 10% at the open Tuesday, hitting the daily limit-down at T$247.50 after posting a Q4 net profit of T$11.083 billion and forecasting further DRAM price hikes. A U.S. bank cut its 2026 EPS outlook but cited ongoing DDR4 shortages. The TAIEX dropped 0.6%. Nanya signaled a lower dividend payout and plans T$50 billion in capital spending for 2026.
20 January 2026
··

Stock Market Today

  • Hidden Dividend Stars: 3 SGX Stocks with Growing Payouts and Zero Debt
    May 21, 2026, 12:41 AM EDT. Three Singapore Exchange (SGX) listed companies-HRnetGroup, Credit Bureau Asia, and an unnamed third-offer rising dividends supported by zero debt and strong cash reserves. HRnetGroup posted a 15% profit increase and 5% dividend rise for FY2025, underpinned by S$262.9 million cash and zero debt. Credit Bureau Asia raised dividends despite a slight profit dip, backed by S$71.1 million in liquid assets and a debt-free balance sheet. These firms illustrate how clean balance sheets combined with rising dividends provide more reliable income than yield alone, especially during economic uncertainty.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop